Skip to navigation Skip to content

Short bowel syndrome (SBS) with intestinal failure Program in Pharmaceutical Benefits Scheme (PBS) 012-19100123

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised teduglutide for patients with short bowel syndrome (SBS) with intestinal failure.

SBS with intestinal failure and listing dates

SBS with intestinal failure is a malabsorption disorder caused by a lack of functional small intestine.

Listing date: teduglutide - 1 October 2019.

See Written Authority Required Drugs for more details.

Enquiries

Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs and choose the option relevant to the condition treated.

The Resources page contains:

  • application forms
  • contact details
  • restriction and item codes
  • the PBS schedule
  • Services Australia website link

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Processing Written Authority approval requests

Written Authority Required Drugs